SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (21632)6/1/1998 6:36:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
bluejeans, Why do you want to confuse the argument with real data? Pretty soon you will be accused of being ne of my "many" aliases.



To: bluejeans who wrote (21632)6/1/1998 9:37:00 PM
From: Machaon  Read Replies (1) | Respond to of 32384
 
a shorter term view:

<< Seragen's fusion proteins have three functional components - a targeting domain that binds with target receptor cells; a "molecular syringe" that pierces the cell membrane; and the toxic portion, which slips inside the cell and destroys it. >>

While we are slowly and painfully losing our arses, on this stock, we might as well see what cards we've been dealt! <g>

This fusion stuff, that LGND gets with Seragen, is some pretty cool stuff. It reminds me of the contraptions that you see in a James Bond movie.

These proteins are some pretty smart dudes, capable of attaching to, and then injecting a poison in a specific type of cell, to kill it.

And.......... all this science is almost totally wasted, right? If, instead of curing cancer, these smart proteins were really smart, they would figure out a way to do what Viagra does, while it is seeking out, and killing cancer cells. Imagine getting your cancer cured, and getting Willy working at the same time! It would be worth billions! <g>

Good luck, Bob




To: bluejeans who wrote (21632)6/2/1998 7:36:00 AM
From: Henry Niman  Respond to of 32384
 
Larger Biotechs fell over 2 % yesterday. LGND actually did relatively well:

techstocks.com



To: bluejeans who wrote (21632)6/2/1998 8:05:00 AM
From: tonyt  Respond to of 32384
 
Re: "a longer term view"

Longer term (100 weeks), VICL is up 40%, LGND 13%. While this is better than the 30 day chart where LGND is down 10%, it still highlights LGND's weakness. (And as your last chart pointed out, an investor would have done better if he just put 15% of the capital that he tied-up in LGND into DELL and flushed the rest down the toilet!)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News